NAFDAC hails Sam Pharmaceuticals’ new lagos facility as boost for local drug production

Business, Health

LAGOS, Nigeria, 9 April 2026 (NPA) — The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) has commended Sam Pharmaceuticals following the commissioning of its new manufacturing facility in Lagos.

NAFDAC described the commissioning of Sam Pharmaceuticals Ltd’s plant as a significant milestone in advancing local pharmaceutical production in Nigeria. The event also featured tributes to the Agency’s Director-General, Professor Mojisola Adeyeye, for her leadership in strengthening the sector through policies that promote quality, safety, and local capacity development.

In a statement issued today, NAFDAC noted that stakeholders at the event highlighted the Agency’s 5+5 Policy as instrumental in driving increased local manufacturing, contributing to a rise in domestic pharmaceutical output. They further acknowledged that NAFDAC’s regulatory reforms and commitment to global best practices have enhanced investor confidence and supported industry growth.

Reaffirming its commitment, NAFDAC pledged to continue fostering a robust and self-sufficient pharmaceutical sector, ensuring the availability of safe, effective, and affordable medicines for Nigerians. The Agency emphasised that sustained collaboration between regulators and industry players remains critical to achieving national drug security and improved healthcare outcomes.